Market Overview

Dan Nathan Sees Unusual Options Activity In Biotech ETF

Related XBI
Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate
Biotech ETFs: What Lies Ahead?
3 Top Risks For Healthcare Investors (Seeking Alpha)

Dan Nathan said on CNBC's "Options Action" that put volume was really high in SPDR S&P Biotech (ETF) (NYSE: XBI) on Thursday. Puts outnumbered calls 3 to 1 as there were several large trades.

When the stock was trading at $74.65, there was a buyer of 10,000 contracts of the September 74/68 put spreads. The trader paid $1.67 for them, which sets the break even for the trade at $72.33 at the September expiration. The trade is going to reach its maximal profit of $4.33, if the stock drops to $68 or lower.

Posted-In: Dan Nathan Options ActionCNBC Sector ETFs Media ETFs


Related Articles (XBI)

View Comments and Join the Discussion!

Partner Center